PharmaNewsDaily.com

PureTech Health acquires LYT-100 for lymphedema treatment

Posted on July 18, 2019 by pharmanewsdaily

US biopharma company PureTech Health has acquired a clinical-stage product candidate called LYT-100, which will be developed as the potential

Merck bags Recarbrio FDA approval for urinary tract and intra-abdominal infections

Posted on July 17, 2019 by pharmanewsdaily

Recarbrio FDA approval : Merck & Co. has secured approval from the US Food and Drug Administration (FDA) for its

Convelo, Genentech to collaborate on remyelination drugs for MS

Posted on July 17, 2019 by pharmanewsdaily

US biotech company Convelo Therapeutics has signed an exclusive worldwide collaboration with Roche subsidiary Genentech to fast track discovery and

Boehringer Ingelheim acquisition of AMAL Therapeutics

Boehringer Ingelheim acquires Swiss biotech company AMAL Therapeutics

Posted on July 16, 2019July 16, 2019 by pharmanewsdaily

Boehringer Ingelheim acquisition of AMAL Therapeutics : German pharma company Boehringer Ingelheim has acquired Swiss biotech company AMAL Therapeutics for

ViiV Healthcare secures Dovato EMA approval for HIV-1 treatment

Posted on July 14, 2019 by pharmanewsdaily

Dovato EMA approval : The European Commission (EC) has approved ViiV Healthcare’s once-daily, single-pill, two-drug regimen Dovato (dolutegravir/lamivudine) for the

Merck to acquire US biopharma company Peloton Therapeutics in $2.2bn deal

Posted on July 14, 2019July 14, 2019 by pharmanewsdaily

Merck acquisition of Peloton : Pharma giant Merck is set to acquire US biopharma company Peloton Therapeutics in a deal

PanTheryx, Zuellig Pharma launch diarrhea drug DiaResQ in Cambodia

Posted on July 14, 2019 by pharmanewsdaily

US biotech company PanTheryx has partnered with Asian healthcare company Zuellig Pharma to launch diarrhea drug DiaResQ in Cambodia. According

Sensorion gets FDA nod for SENS-401 trial for inner ear condition

Posted on July 13, 2019 by pharmanewsdaily

French inner ear diseases company Sensorion has secured the investigational new drug (IND) clearance from the US Food and Drug

Gilead Sciences names Lilly senior VP Christi L. Shaw as Kite CEO

Posted on July 12, 2019 by pharmanewsdaily

US biopharma company Gilead Sciences has named Christi L. Shaw as the new chief executive officer of its subsidiary Kite,

Clover Health launches chronic diseases-focused Clover Therapeutics

Posted on July 10, 2019 by pharmanewsdaily

California-based healthcare company Clover Health has launched a new research subsidiary, called Clover Therapeutics, which will focus on developing drugs